336 related articles for article (PubMed ID: 2982946)
1. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody.
Suzuki T; Butler JL; Cooper MD
J Immunol; 1985 Apr; 134(4):2470-6. PubMed ID: 2982946
[TBL] [Abstract][Full Text] [Related]
2. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the expression of IL 2 receptors by human T and B cells: induction by the polyclonal mitogens, phorbol myristate acetate, and anti-mu antibody.
Suzuki T; Cooper MD
J Immunol; 1985 May; 134(5):3111-9. PubMed ID: 2580014
[TBL] [Abstract][Full Text] [Related]
4. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
5. Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I.
Kehrl JH; Muraguchi A; Fauci AS
Eur J Immunol; 1984 Feb; 14(2):115-21. PubMed ID: 6199210
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M
Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40).
Ledbetter JA; Shu G; Gallagher M; Clark EA
J Immunol; 1987 Feb; 138(3):788-94. PubMed ID: 3492534
[TBL] [Abstract][Full Text] [Related]
8. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
Maruyama S; Kubagawa H; Cooper MD
J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
[TBL] [Abstract][Full Text] [Related]
9. B cell growth-promoting activity of recombinant human interleukin 4.
Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE
J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225
[TBL] [Abstract][Full Text] [Related]
10. Functional properties of two human B cell growth factor species separated by lectin affinity column.
Dugas B; Vazquez A; Geŕard JP; Richard Y; Auffredou MT; Delfraissy JF; Fradelizi D; Galanaud P
J Immunol; 1985 Jul; 135(1):333-8. PubMed ID: 3923105
[TBL] [Abstract][Full Text] [Related]
11. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig.
Muraguchi A; Kehrl JH; Butler JL; Fauci AS
J Immunol; 1984 Jan; 132(1):176-80. PubMed ID: 6197443
[TBL] [Abstract][Full Text] [Related]
12. Comparative activation requirements of human peripheral blood, spleen, and lymph node B cells.
Jelinek DF; Lipsky PE
J Immunol; 1987 Aug; 139(4):1005-13. PubMed ID: 3112218
[TBL] [Abstract][Full Text] [Related]
13. The role of the transferrin receptor in human B lymphocyte activation.
Neckers LM; Yenokida G; James SP
J Immunol; 1984 Nov; 133(5):2437-41. PubMed ID: 6090534
[TBL] [Abstract][Full Text] [Related]
14. The effects of interleukin 1 on human B cell activation and proliferation.
Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS
J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of cell activation markers after stimulation of resting human B lymphocytes.
Kehrl JH; Muraguchi A; Fauci AS
J Immunol; 1984 Jun; 132(6):2857-61. PubMed ID: 6427329
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
Kawano M; Iwato K; Kuramoto A
J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of B cell growth factor (BCGF) by monoclonal antibodies directed against the C3d receptor (CR2).
Perri RT; Wilson BS; Kay NE
Eur J Immunol; 1986 Apr; 16(4):350-5. PubMed ID: 2938967
[TBL] [Abstract][Full Text] [Related]
18. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF).
Vazquez A; Gérard JP; Olive D; Auffredou MT; Dugas B; Karray S; Delfraissy JF; Galanaud P
Eur J Immunol; 1986 Dec; 16(12):1503-7. PubMed ID: 3102243
[TBL] [Abstract][Full Text] [Related]
19. B cell-derived BCGF functions as autocrine growth factor(s) in normal and transformed B lymphocytes.
Muraguchi A; Nishimoto H; Kawamura N; Hori A; Kishimoto T
J Immunol; 1986 Jul; 137(1):179-86. PubMed ID: 3486912
[TBL] [Abstract][Full Text] [Related]
20. Activity of a partially purified human BCGF on murine assays for B cell stimulatory factors. II. Synergy between two distinct BCGF II-like factors in promoting B cell differentiation.
Ennist DL; Elkins KL; Cheng SC; Howard M
J Immunol; 1987 Sep; 139(5):1525-31. PubMed ID: 2957428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
